These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7599336)

  • 41. Nitric oxide donor-mediated killing of bioluminescent Escherichia coli.
    Virta M; Karp M; Vuorinen P
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2775-9. PubMed ID: 7695261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Labelling of blood platelets with stable tracers.
    Del Principe D; Cesareo R; Tallarida BM; Ciancarelli MG; Ricci M; Mancuso G
    Thromb Haemost; 1980 Aug; 44(1):30-1. PubMed ID: 7423442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nitric oxide: physiology, pathophysiology, and pharmacology.
    Moncada S; Palmer RM; Higgs EA
    Pharmacol Rev; 1991 Jun; 43(2):109-42. PubMed ID: 1852778
    [No Abstract]   [Full Text] [Related]  

  • 44. Nitric oxide in platelets.
    Radomski MW; Zakar T; Salas E
    Methods Enzymol; 1996; 269():88-107. PubMed ID: 8791640
    [No Abstract]   [Full Text] [Related]  

  • 45. The release of histamine, potassium and nitrogen from blood platelets by chlorpromazine in vitro.
    Paasonen MK; Solatunturi E
    Ann Med Exp Biol Fenn; 1965; 43(4):241-4. PubMed ID: 5855590
    [No Abstract]   [Full Text] [Related]  

  • 46. In reply.
    Park JW; Piknova B; Schechter AN
    Transfusion; 2013 Jan; 53(1):235. PubMed ID: 23294214
    [No Abstract]   [Full Text] [Related]  

  • 47. [International symposium on the biological effects of molsidomine and its metabolites. Lyons, 9 September 1986].
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):211-65. PubMed ID: 3550636
    [No Abstract]   [Full Text] [Related]  

  • 48. Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine.
    Stupnisek M; Kokot A; Drmic D; Hrelec Patrlj M; Zenko Sever A; Kolenc D; Radic B; Suran J; Bojic D; Vcev A; Seiwerth S; Sikiric P
    PLoS One; 2015; 10(4):e0123454. PubMed ID: 25897838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Administration of glutathione in patients with type 2 diabetes mellitus increases the platelet constitutive nitric oxide synthase activity and reduces PAI-1.
    Martina V; Bruno GA; Zumpano E; Origlia C; Quaranta L; Pescarmona GP
    J Endocrinol Invest; 2001 Jan; 24(1):37-41. PubMed ID: 11227730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Attenuation by prolonged nitric oxide synthase inhibition of the enhancement of fibrinolysis caused by environmental stress in the rat.
    Kawabata A; Hata T
    Br J Pharmacol; 1996 Sep; 119(2):346-50. PubMed ID: 8886419
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Progress on study of experimental physico-chemical indexes related with ischemic stroke].
    Li ZG; Zhu MZ; Wei GL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Apr; 23(4):316-8. PubMed ID: 12764922
    [No Abstract]   [Full Text] [Related]  

  • 52. The effect of nitric oxide donors on the release of plasminogen activator inhibitor (PAI) from rabbit platelets in vitro.
    Korbut R; Marcinkiewicz E; Cieślik K; Gryglewski RJ
    J Physiol Pharmacol; 1995 Mar; 46(1):37-44. PubMed ID: 7599336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The nitric oxide donor SIN-1 is a potent inhibitor of plasminogen activator inhibitor release from stimulated platelets.
    Drummer C; Lüdke S; Spannagl M; Schramm W; Gerzer R
    Thromb Res; 1991 Sep; 63(5):553-6. PubMed ID: 1755008
    [No Abstract]   [Full Text] [Related]  

  • 54. Modulation of angiotensin-converting enzyme by nitric oxide.
    Ackermann A; Fernández-Alfonso MS; Sánchez de Rojas R; Ortega T; Paul M; González C
    Br J Pharmacol; 1998 May; 124(2):291-8. PubMed ID: 9641545
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nitric oxide as a regulator of prostacyclin synthesis in cultured rat heart endothelial cells.
    Sievi E; Lähteenmäki TA; Alanko J; Vuorinen P; Vapaatalo H
    Arzneimittelforschung; 1997 Oct; 47(10):1093-8. PubMed ID: 9368700
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.